Pheochromocytomas Completed Phase 3 Trials for Filgrastim (DB00099)

Also known as: Pheochromocytoma / Chromaffin cell neoplasm (morphologic abnormality) / Phaeochromocytoma / Pheochromocytoma (morphologic abnormality) / Phaeochromocytoma [Ambiguous]

IndicationStatusPhase
DBCOND0071316 (Pheochromocytomas)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00002641Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue SarcomaTreatment
NCT00002764Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue SarcomaTreatment